Business Description
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
Business History
Price Overview
Last updated: Jun 27, 2026 9:01am (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 0.90
Total Equity: $43.21M
Shares: 8,718,900
Total Debt: $0.00
Cash: $15.29M
EBITDA: $11.46M
Total Debt: $0.00
Cash: $15.29M
Revenue: $64.00M
Revenue: $64.00M
Revenue: $64.00M
Total Equity: $43.21M
Tax Rate: 26.7%
Equity: $43.21M
Total Debt: $0.00
Cash: $15.29M
Current Liabilities: $10.47M
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $43.21M
Shares: 8,718,900
Shares: 8,718,900
CapEx: -$306,000
Shares: 8,718,900
Stock Price: $41.46
Net Income: $7.54M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 22, 2026 7:34pm (4d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $35.8M | $41.7M | $48.1M | $54.7M | $64.0M |
| Cost of Revenue | $8.5M | $10.2M | $11.5M | $13.0M | $14.0M |
| Gross Profit | $27.3M | $31.4M | $36.5M | $41.7M | $50.0M |
| Operating Expenses | $24.2M | $28.5M | $32.5M | $35.1M | $40.1M |
| Operating Income | $3.1M | $3.0M | $4.0M | $6.6M | $9.9M |
| Net Income | $2.4M | $2.3M | $3.2M | $5.2M | $7.5M |
| EBITDA | $3.8M | $3.6M | $4.7M | $7.9M | $11.5M |
| EPS | $0.28 | $0.27 | $0.37 | $0.60 | $0.90 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 22, 2026 7:34pm (4d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $11.9M | $8.2M | $7.4M | $16.1M | $15.3M |
| Total Current Assets | $31.7M | $34.5M | $37.8M | $44.2M | $45.1M |
| Total Assets | $37.1M | $41.4M | $45.8M | $52.2M | $53.8M |
| Current Liabilities | $4.6M | $7.2M | $8.1M | $7.7M | $10.5M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $4.7M | $7.2M | $8.1M | $7.7M | $10.6M |
| Total Equity | $32.4M | $34.2M | $37.7M | $44.5M | $43.2M |
| Retained Earnings | $14.9M | $15.8M | $18.8M | $23.7M | $21.2M |
Cash Flow (Annual)
Last updated: Jun 22, 2026 7:34pm (4d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $3.1M | $-686,000 | $1.3M | $9.1M | $11.4M |
| Capital Expenditure | $-448,000 | -$1.5M | -$1.7M | $-395,000 | $-306,000 |
| Free Cash Flow | $2.6M | -$2.2M | $-401,000 | $8.7M | $11.1M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$1.1M | -$1.4M | $-153,000 | $-275,000 | -$10.0M |
| Net Change in Cash | $1.4M | -$3.7M | $-781,000 | $8.7M | $-793,000 |
Analyst Estimates (Annual)
Last updated: Jun 26, 2026 8:18pm (12h ago)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$83.6M $83.1M – $83.9M
|
$91.5M $91.0M – $91.9M
|
$81.7M $81.2M – $82.0M
|
$85.8M $85.3M – $86.2M
|
| EBITDA |
$22.6M $22.5M – $22.7M
|
$24.7M $24.6M – $24.8M
|
$22.1M $21.9M – $22.2M
|
$23.2M $23.1M – $23.3M
|
| Net Income |
$12.8M $12.8M – $13.0M
|
$15.4M $15.3M – $15.5M
|
$9.5M $9.4M – $9.6M
|
$10.0M $10.0M – $10.1M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 22, 2026 7:34pm (4d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +16.5% | +15.4% | +13.8% | +17.0% |
| Gross Profit Growth | +15.2% | +16.1% | +14.3% | +19.8% |
| Operating Income Growth | -5.4% | +34.9% | +64.2% | +50.0% |
| Net Income Growth | -2.4% | +37.4% | +62.7% | +46.3% |
| EBITDA Growth | -4.0% | +29.6% | +67.6% | +45.4% |
Insider Trading (Recent)
All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-08 | Cunniff James L. | M-Exempt | 9,700.00 | $17.25 | $167,325 |
| 2026-06-08 | Cunniff James L. | S-Sale | 7,003.00 | $36.25 | $253,852 |
| 2026-06-08 | Cunniff James L. | S-Sale | 1,671.00 | $36.80 | $61,489 |
| 2026-06-08 | Cunniff James L. | S-Sale | 1,026.00 | $37.77 | $38,755 |
| 2026-06-08 | Cunniff James L. | M-Exempt | 9,700.00 | $17.25 | $167,325 |
| 2026-06-04 | Nagel Bradley M. | M-Exempt | 5,267.00 | $10.71 | $56,410 |
| 2026-06-04 | Nagel Bradley M. | M-Exempt | 4,334.00 | $10.25 | $44,424 |
| 2026-06-04 | Nagel Bradley M. | S-Sale | 11,620.00 | $36.34 | $422,219 |
| 2026-06-04 | Nagel Bradley M. | S-Sale | 181.00 | $37.11 | $6,718 |
| 2026-06-04 | Nagel Bradley M. | M-Exempt | 5,267.00 | $10.71 | $56,410 |
| 2026-06-04 | Nagel Bradley M. | M-Exempt | 4,334.00 | $10.25 | $44,424 |
| 2026-05-15 | SKARVAN KATHLEEN | M-Exempt | 40,000.00 | $3.82 | $152,800 |
| 2026-05-15 | SKARVAN KATHLEEN | S-Sale | 8,150.00 | $34.36 | $280,055 |
| 2026-05-15 | SKARVAN KATHLEEN | S-Sale | 19,032.00 | $35.24 | $670,730 |
| 2026-05-15 | SKARVAN KATHLEEN | S-Sale | 9,256.00 | $36.26 | $335,604 |
| 2026-05-15 | SKARVAN KATHLEEN | S-Sale | 3,562.00 | $37.33 | $132,969 |
| 2026-05-15 | SKARVAN KATHLEEN | M-Exempt | 40,000.00 | $3.82 | $152,800 |
| 2025-12-01 | Tune Kathleen A | A-Award | 3,000.00 | $0.00 | $0 |
| 2025-12-01 | Erickson Stan K. | A-Award | 3,000.00 | $0.00 | $0 |
| 2025-12-01 | Fluet Gregory | A-Award | 3,000.00 | $0.00 | $0 |
Narrative Economics
market-narrative step).